1. Home
  2. FGEN vs SHOT Comparison

FGEN vs SHOT Comparison

Compare FGEN & SHOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FGEN
  • SHOT
  • Stock Information
  • Founded
  • FGEN 1993
  • SHOT 2018
  • Country
  • FGEN United States
  • SHOT United States
  • Employees
  • FGEN N/A
  • SHOT N/A
  • Industry
  • FGEN Biotechnology: Pharmaceutical Preparations
  • SHOT Biotechnology: Pharmaceutical Preparations
  • Sector
  • FGEN Health Care
  • SHOT Health Care
  • Exchange
  • FGEN Nasdaq
  • SHOT Nasdaq
  • Market Cap
  • FGEN 33.5M
  • SHOT 37.9M
  • IPO Year
  • FGEN 2014
  • SHOT 2020
  • Fundamental
  • Price
  • FGEN $0.30
  • SHOT $0.44
  • Analyst Decision
  • FGEN Strong Buy
  • SHOT
  • Analyst Count
  • FGEN 1
  • SHOT 0
  • Target Price
  • FGEN $10.00
  • SHOT N/A
  • AVG Volume (30 Days)
  • FGEN 594.8K
  • SHOT 1.6M
  • Earning Date
  • FGEN 05-12-2025
  • SHOT 05-23-2025
  • Dividend Yield
  • FGEN N/A
  • SHOT N/A
  • EPS Growth
  • FGEN N/A
  • SHOT N/A
  • EPS
  • FGEN N/A
  • SHOT N/A
  • Revenue
  • FGEN $6,996,000.00
  • SHOT $701,967.00
  • Revenue This Year
  • FGEN $232.81
  • SHOT N/A
  • Revenue Next Year
  • FGEN $9.16
  • SHOT N/A
  • P/E Ratio
  • FGEN N/A
  • SHOT N/A
  • Revenue Growth
  • FGEN N/A
  • SHOT 246.36
  • 52 Week Low
  • FGEN $0.18
  • SHOT $0.34
  • 52 Week High
  • FGEN $1.74
  • SHOT $1.77
  • Technical
  • Relative Strength Index (RSI)
  • FGEN 44.76
  • SHOT 43.73
  • Support Level
  • FGEN $0.29
  • SHOT $0.47
  • Resistance Level
  • FGEN $0.32
  • SHOT $0.52
  • Average True Range (ATR)
  • FGEN 0.02
  • SHOT 0.06
  • MACD
  • FGEN 0.00
  • SHOT -0.00
  • Stochastic Oscillator
  • FGEN 26.25
  • SHOT 23.31

About FGEN FibroGen Inc

FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates. Geographically, it operates in United States, Japan, Europe and Others.

About SHOT Safety Shot Inc.

Safety Shot Inc is a wellness and functional beverage company. It is set to launch Safety Shot, the patented beverage that helps people feel faster by reducing blood alcohol content and boosting clarity.

Share on Social Networks: